Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03220646
Title Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

glioblastoma

malignant astrocytoma

oligodendroglioma

meningioma

high grade glioma

central nervous system lymphoma

high grade ependymoma

Therapies

Abemaciclib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Hartford Healthcare Cancer Institute @ Hartford Hospital (Data collection only) Hartford Connecticut 06102 United States Details
Memoral Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge New Jersey 07920 United States Details
Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Commack (All Protocol Activities) Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester (All Protocol Activities) Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York New York 10065 United States Details
Lehigh Valley Health Network Allentown Pennsylvania 18103 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field